A polymeric bacterial protein activates dendritic cells via TLR4

Journal of Immunology

Volumn 176, Issue 4, 2006, Pages 2366-2372

  Berguer, Paula M ^a   Mundiñano, Juliana ^b   Piazzon, Isabel ^b   Goldbaum, Fernando A ^a  

^a FUNDACIÓN INSTITUTO LELOIR   (Argentina)

^b INST DE INVEST HEMATOLOGICAS   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; BACTERIAL PROTEIN; CD40 ANTIGEN; CD86 ANTIGEN; CYTOKINE; DNA VACCINE; ENDOTOXIN; GLYCOPROTEIN P 15095; INTERLEUKIN 12P70; INTERLEUKIN 4; INTERLEUKIN 6; LUMAZINE; LUMAZINE SYNTHASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; PADGEM PROTEIN; SYNTHETASE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRUCELLA; CELL ACTIVATION; CHIMERA; CONGENIC STRAIN; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNOGENICITY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PURIFICATION; RIBONUCLEASE PROTECTION ASSAY;

EID: 32044471572     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.4.2366     Document Type: Article

References (45)

1. Bachmann, M. F., and M. Kopf. 1999. The role of B cells in acute and chronic infections. Curr. Opin. Immunol. 11: 332-339.
2. Nieba, L., and M. F. Bachmann. 2000. A new generation of vaccines. Mod. Asp. Immunobiol. 1: 36-39.
3. Bachmann, M. F., U. H. Rohrer, T. M. Kundig, K. Burki, H. Hengartner, and R. M. Zinkemagel. 1993. The influence of antigen organization on B cell responsiveness. Science 262: 1448-1451.
4. Man, N., A. J. Cartwright, K. M. Andrews, and G. E. Morris. 1989. Treatment of human muscle creatine kinase with glutaraldehyde preferentially increases the immunogenicity of the native conformation and permits production of high-affinity monoclonal antibodies which recognize two distinct surface epitopes. J. Immunol. Methods 125: 251-259.
5. Korematsu, S., Y. Tanaka, S. Hosoi, S. Koyanagi, T. Yokota, B. Mikami, and N. Minato. 2000. C8/119S mutation of major mite allergen Derf-2 leads to degenerate secondary structure and molecular polymerization and induces potent and exclusive Th1 cell differentiation. J. Immunol. 165: 2895-2902.
6. St Clair, N., B. Shenoy, L. D. Jacob, and A. L. Margolin. 1999. Cross-linked protein crystals for vaccine delivery. Proc. Natl. Acad. Sci. USA 96: 9469-9474.
7. Bachmann, M. F., and R. M. Zinkernagel. 1996. The influence of virus structure on antibody responses and virus serotype formation. Immunol. Today 17: 553-558.
8. Raz, R., R. Dagan, A. Gallil, G. Brill, I. Kassis, and R. Koren. 1996. Safely and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens in children. Vaccine 14: 207-211.
9. Sulzer, B., and A. S. Perelson. 1997. Immunons revisited: binding of multivalent antigens to B cells. Mol. Immunol. 34: 63-74.
10. Baldi, P. C., G. H. Giambartolomei, F. A. Goldbaum, L. F. Abdon, C. A. Velikovsky, R. Kittelberger, and C. A. Fossati. 1996. Humoral immune response against lipopolysaccharide and cytoplasmic proteins of Brucella abortus in cattle vaccinated with B. abortus S19 or experimentally infected with Yersinia enterocolitica serotype 0:9. Clin. Diagn. Lab. Immunol. 3: 472-476.
11. Goldbaum, F. A., J. Leoni, J. C. Wallach, and C. A. Fossati. 1993. Characterization of an 18-kilodalton Brucella cytoplasmic protein which appears to be a serological marker of active infection of both human and bovine brucellosis. J. Clin. Microbiol. 31: 2141-2145.
12. Velikovsky, C. A., F. A. Goldbaum, J. Cassataro, S. Estein, R. A. Bowden, L. Bruno, C. A. Fossati, and G. H. Giambartolomei. 2003. Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used. Infect. Immun. 71: 5750-5755.
13. Velikovsky, C. A., J. Cassataro, M. Sanchez, C. A. Fossati, L. Fainboim, and M. Spitz. 2000. Single-shot plasmid DNA intrasplenic immunization for the production of monoclonal antibodies: persistent expression of DNA. J. Immunol. Methods 244: 1-7.
14. Velikovsky, C. A., J. Cassataro, G. H. Giambartolomei, F. A. Goldbaum, S. Estein, R. A. Bowden, L. Bruno, C. A. Fossati, and M. Spitz. 2002. A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice. Infect. Immun. 70: 2507-2511.
15. Laplagne, D. A., V. Zylberman, N. Ainciart, M. W. Steward, E. Sciutto, C. A. Fossati, and F. A. Goldbaum. 2004. Engineering of a polymeric bacterial protein as a scaffold for the multiple display of peptides. Proteins 57: 820-828.
16. Sciutto, E., A. Toledo, C. Cruz, G. Rosas, G. Meneses, D. Laplagne, N. Ainciart, J. Cervantes, G. Fragoso, and F. A. Goldbaum. 2005. Brucella spp. lumazine synthase: a novel antigen delivery system. Vaccine 23: 2784-2790.
17. Craig, P. O., P. Berguer, N. Ainciart, V. Zylberman, M. G. Thomas, L. J. Martinez Tosar, A. Bulloj, G. L. Boccaccio, and F. A. Goldbaum. 2005. Multiple display of a protein domain on a bacterial polymeric scaffold. Proteins 61: 1089-1100.
18. Braden, B. C., C. A. Velikovsky, A. A. Cauerhff, I. Polikarpov, and F. A. Goldbaum. 2000. Divergence in macromolecular assembly: x-ray crystallographic structure analysis of lumazine synthase from Brucella abortus. J. Mol. Biol. 297: 1031-1036.
19. Zylberman, V., P. O. Craig, S. Klinke, B. C. Braden, A. Cauerhff, and F. A. Goldbaum. 2004. High order quaternary arrangement confers increased structural stability to Brucella spp. lumazine synthase. J. Biol. Chem. 279: 8093-8101.
20. Bhakuni, V., D. Xie, and E. Freire. 1991. Thermodynamic identification of stable folding intermediates in the B-subunit of cholera toxin. Biochemistry 30: 5055-5060.
21. Ruddock, L. W., S. P. Ruston, S. M. Kelly, N. C. Price, R. B. Freedman, and T. R. Hirst. 1995. Kinetics of acid-mediated disassembly of the B subunit pentamer of Escherichia coli heat-labile enterotoxin: molecular basis of pH stability. J. Biol. Chem. 270: 29953-29958.
22. Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, and S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 11: 443-451.
23. National Academy Press. 1996. Guide for the Care and Use of Laboratory Animals. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Academy Press, Washington, D.C.
24. Lutz, M. P., N. Kukutsch, A. L. J. Ogilvie, S. Röbner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223: 77-92.
25. Goldbaum, F. A., C. A. Velikovsky, P. C. Baldi, S. Mortl, A. Bacher, and C. A. Fossati. 1999. The 18-kDa cytoplasmic protein of Brucella species-an antigen useful for diagnosis-is a lumazine synthase. J. Med. Microbiol. 48: 833-839.
26. Martin, P., S. Ruiz, Ruiz, G. Martinez del Hoyo, F. Anjuère, H. Hernández Vargas, M. López-Bravo, and C. Ardavin. 2002. Dramatic increase in lymph node dendritic cell number during infection by the mouse mammary tumor virus occurs by a CD62L-dependent blood-borne DC recruitment. Blood 99: 1282-1288.
27. Underhill, D. M., and A. Ozinsky. 2002. Toll-like receptors: key mediators of microbe detection. Curr. Opin. Immunol. 14: 103-110.
28. Barton, G. M., and R. Medzhitov. 2002. Control of adaptive immune responses by Toll-like receptors. Curr. Opin. Immunol. 14: 380-383.
29. Jiang, Z. H., and R. R. Koganty. 2003. Synthetic vaccines: the role of adjuvants in immune targeting. Curr. Med. Chem. 10: 1423-1439.
30. Baldridge, J. R., P. McGowan, J. T. Evans, C. Cluff, S. Mossman, D. Johnson, and D. Persing. 2004. Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents. Exp. Opin. Biol. Ther. 4: 1129-1138.
31. Visser, L., H. J. de Heer, L. A. Boven, D. van Riel, M. van Meurs, M. J. Melief, U. Zahringer, J. van Strijp, B. N. Lambrecht, E. E. Nieuwenhuis, and J. D. Laman. 2005. Proinflammatory bacterial peptidoglycan as a cofactor for the development of central nervous system autoimmune disease. J. Immunol. 174: 808-816.
32. West, M. A., R. P. A. Wallin, S. P. Matthews, H. G. Svensson, R. Zaru, H. Ljunggren, A. R. Prescott, and C. Watts. 2004. Enhanced dendritic cell antigen capture via Toll-like receptor induced actin remodeling. Science 305: 1153-1157.
33. Tsan, M. F., and B. Gao. 2004. Endogenous ligands of Toll-like receptors. J. Leukocyte Biol. 76: 514-519.
34. Majde, J. A. 1993. Microbial cell-wall contaminants in peptides: a potential source of physiological artifacts. Peptides 14: 629-632.
35. Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1: 135-145.
36. Lee, H. K., J. Lee, and P. S. Tobias. 2002. Two lipoproteins extracted from Escherichia coli K-12 LCD25 lipopolysaccharide are the major components responsible for Toll-like receptor 2-mediated signaling. J. Immunol. 168: 4012-4017.
37. Gao, B., and M. F. Tsan. 2003. Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor α release by murine macrophages. J. Biol. Chem. 278: 174-179.
38. Gao, B., and M. F. Tsan. 2003. Recombinant human heat shock protein 60 does not induce the release of tumor necrosis factor from murine macrophages. J. Biol. Chem. 278: 22523-22529.
39. Tsan, M. F., and B. Gao. 2004. Cytokine function of heat shock proteins. Am. J. Physiol 286: C739-C744.
40. Gorczynski, R. M., C. Alexander, W. Bessler, K. Fournier, P. Hoffmann, J. P. Mach, J. Manuel, V. Ramakrishna, E. T. Rietschel, L. Song, et al. 2004. Characterization of an interaction between fetal hemoglobin and lipid A of LPS resulting in augmented induction of cytokine production in vivo and in vitro. Int. Immunopharmacol. 4: 1859-1872.
41. Burzyn, D., J. C. Rassa, D. Kim, I. Nepomnaschy, S. R. Ross, and I. Piazzon. 2004. Toll-like receptor 4-dependent activation of dendritic cells by a retrovirus. J. Virol. 78: 576-584.
42. Cravens, P. V., and P. E. Lipsky. 2002. Dendritic cells, chemokine receptors and autoimmune inflammatory diseases. Immunol. Cell Biol. 80: 497-505.
43. Sozzani, S., P. Allavena, A. Veehi, and A. Mantovani. 1999. The role of chemokines in the regulation of dendritic cell trafficking. J. Leukocyte Biol. 66: 1-9.
44. Yang, R., F. M. Murillo, H. Cui, R. Blosser, S. Uematsu, K. Takeda, S. Akira, R. P. Viscidi, and R. B. Roden. 2004. Papillomavirus-like particles stimulate murine bone marrow-derived dendritic cells to produce α interferon and Th1 immune responses via MyD88. J. Virol. 78: 11152-11160.
45. Yan, M., J. Peng, I. A. Jabbar, X. Liu, L. Filgueira, I. H. Frazer, and R. Thomas. 2005. Activation of dendritic cells by human papillomavirus-like particles through TLR4 and NF-κB-mediated signalling, moderated by TGF-β. Immunol. Cell Biol. 83: 83-91.